Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
- See the issue
Share
Epidemiologia e Serviços de Saúde
Print version ISSN 1679-4974On-line version ISSN 2237-9622
Epidemiol. Serv. Saúde vol.27 no.2 Brasília June 2018 Epub June 28, 2018
http://dx.doi.org/10.5123/s1679-49742018000200026
This corrects the article: 10.5123/s1679-49742018000200002
This corrects the article: 10.5123/s1679-49742017000300016
This corrects the article: 10.5123/S1679-49742018000200007
This corrects the article: 10.5123/S1679-49742018000200014
ERRATUM
Erratum
In the article “Attendance of children and adolescents with psychoactive substance use disorders performed by Psychosocial Care Centers in Brazil, 2008-2012”, doi No. http://dx.doi.org/10.5123/s1679-49742018000200002, published on Epidemiology and Health Services, v. 27(2):1-12:
Original text:
The ethnicity/skin color white was indicated in 29.1% of records, followed by brown, with 19.6%, and black, with 4.8%.
Variables | Year | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2008 | 2009 | 2010 | 2011 | 2012 | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | |
Sex | ||||||||||||
Female | 3,941 | 19.4 | 4,131 | 17.5 | 5,490 | 17.8 | 6,755 | 18.1 | 8,081 | 20.7 | 28,398 | 18.8 |
Male | 16,501 | 80.7 | 19,531 | 82.5 | 25,412 | 82.2 | 30,580 | 81.9 | 30,908 | 79.3 | 122,932 | 81.2 |
Age group (in years) | ||||||||||||
5-9 | 256 | 1.2 | 201 | 0.8 | 219 | 0.7 | 298 | 0.8 | 213 | 0.5 | 1,187 | 0.8 |
10-14 | 3,540 | 17.3 | 3,879 | 16.5 | 4,783 | 15.5 | 5,200 | 13.9 | 5,608 | 14.5 | 23,010 | 15.3 |
15-19 | 16,646 | 81.4 | 19,582 | 2.8 | 25,900 | 83.8 | 31,837 | 85.3 | 33,168 | 5.1 | 127,133 | 4.0 |
Ethnicity/skin color | ||||||||||||
White | 6,835 | 33.4 | 7,105 | 30.0 | 8,083 | 26.2 | 10,434 | 27.9 | 11,584 | 29.7 | 44,041 | 29.1 |
Black | 1,136 | 5.6 | 1,145 | 4.8 | 1,482 | 4.8 | 1,741 | 4.7 | 1,828 | 4.7 | 7,332 | 4.8 |
Brown | 4,245 | 20.8 | 4,353 | 18.4 | 5,373 | 17.4 | 7,381 | 19.8 | 8,268 | 21.2 | 29,620 | 19.6 |
Asian | 274 | 1.3 | 284 | 1.2 | 264 | 0.8 | 261 | 0.7 | 448 | 1.1 | 1,531 | 1.0 |
Indigenous | 9 | 0.0 | 5 | 0.0 | 3 | 0.0 | 22 | 0.1 | 30 | 0.1 | 69 | 0.0 |
No information | 7,943 | 38.9 | 10,770 | 45.5 | 15,697 | 50.8 | 17,496 | 46.9 | 16,831 | 43.2 | 68,737 | 45.4 |
Cause of attendance | ||||||||||||
F10 a (alcohol) | 2,242 | 11.0 | 2,620 | 11.1 | 2,699 | 8.7 | 2,849 | 7.6 | 3,207 | 8.2 | 13,617 | 9.0 |
F11 b (opioid) | 80 | 0.4 | 76 | 0.3 | 86 | 0.3 | 123 | 0.3 | 182 | 0.5 | 547 | 0.4 |
F12 c (cannabinoids) | 2,924 | 14.3 | 3,600 | 15.2 | 4,455 | 14.4 | 5,870 | 15.7 | 6,729 | 17.2 | 23,578 | 15.6 |
F13 d (sedatives) | 62 | 0.3 | 51 | 0.2 | 92 | 0.3 | 120 | 0.3 | 53 | 0.1 | 378 | 0.2 |
F14 e (cocaine) | 2,511 | 12.3 | 3,284 | 13.9 | 5,145 | 16.6 | 6,721 | 18.0 | 6,026 | 15.5 | 23,687 | 15.6 |
F15 f (stimulants) | 150 | 0.7 | 49 | 0.2 | 71 | 0.2 | 151 | 0.4 | 181 | 0.5 | 602 | 0.4 |
F16 g (hallucinogens) | 29 | 0.1 | 50 | 0.2 | 51 | 0.2 | 226 | 0.6 | 70 | 0.2 | 426 | 0.3 |
F17 h (tobacco) | 258 | 1.3 | 186 | 0.8 | 262 | 0.8 | 312 | 0.8 | 321 | 0.8 | 1,339 | 0.9 |
F18 i (solvents) | 470 | 2.3 | 294 | 1.2 | 255 | 0.8 | 197 | 0.5 | 161 | 0.4 | 1,377 | 0.9 |
F19 j (multiples SPAk) | 11,716 | 57.3 | 13,452 | 56.8 | 17,786 | 57.6 | 20,766 | 55.6 | 22,059 | 56.6 | 85,779 | 56.7 |
Total | 20,442 | 13.5 | 23,662 | 15.6 | 30,902 | 20.4 | 37,335 | 24.7 | 39,119 | 25.8 | 151,330 | 100.0 |
a) F10: Mental and behavioral disorders due to use of alcohol.
b) F11: Mental and behavioural disorders due to use of opioids.
c) F12: Mental and behavioral disorders due to use of cannabinoids.
d) F13: Mental and behavioral disorders due to the use of sedatives and hypnotics.
e) F14: Mental and behavioral disorders due to use of cocaine.
f) F15: Mental and behavioral disorders due to use of other stimulants, including caffeine.
g) F16: Mental and behavioral disorders due to the use of hallucinogens.
h) F17: Mental and behavioral disorders due to use of tobacco.
i) F18: Mental and behavioral disorders due to use of volatile solvents.
j) F19: Mental and behavioral disorders due to use of multiple drugs and the use of other psychoactive substances.
k) SPA: Psychoactive Substances.
Sources: Authorization for outpatient procedures (APAC); International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10).
Type of CAPS | Region | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
North | Northeast | Southeast | South | Midwest | ||||||||
n | % | n | % | n (63,165) | % | n | % | n | % | n | % | |
CAPS Ia | 210 | 5.7 | 2,098 | 7.4 | 981 | 1.5 | 2,416 | 5.3 | 307 | 2.8 | 6,012 | 4.0 |
CAPS IIb | 98 | 2.7 | 417 | 1.5 | 4,645 | 7.3 | 215 | 0.5 | 7 | 0.1 | 5,382 | 3.6 |
CAPS IIIc | 6 | 0.2 | 176 | 0.6 | 222 | 0.3 | 17 | 0.0 | 95 | 0.9 | 516 | 0.3 |
CAPSid | 39 | 1.7 | 2,664 | 9.4 | 6,380 | 10.1 | 6,482 | 14.3 | 129 | 1.2 | 15,694 | 10.4 |
CAPS ADe / CAPS AD IIIf | 3,322 | 90.4 | 22,973 | 81.1 | 50,937 | 80.6 | 36,245 | 79.9 | 10,249 | 95.0 | 123,726 | 81.8 |
Total | 3,975 | 100.0 | 28,328 | 100.0 | 63,165 | 100.0 | 45,375 | 100.0 | 10,787 | 100.0 | 151,330 | 100.0 |
a) CAPS I: Psychosocial Care Center type I.
b) CAPS II: Psychosocial Care Center type II.
c) CAPS III: Psychosocial Care Center type III.
d) CAPSi: Psychosocial Care Center for Childhood and Youth.
e) CAPS AD: Psychosocial Care Center for Alcohol and other Drugs.
f) CAPS AD III: Psychosocial Care Center for Alcohol and other Drugs 24 Hours.
Sources: Authorization for outpatient procedures (APAC); National Database on Health Units (CNES).
Corrected text:
The ethnicity/skin color white was indicated in 29.1% of records, followed by brown, with 19.6%, and black, with 4.9%.
Variables | Year | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2008 | 2009 | 2010 | 2011 | 2012 | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | |
Sex | ||||||||||||
Female | 3,941 | 19.3 | 4,131 | 17.5 | 5,490 | 17.8 | 6,755 | 18.1 | 8,081 | 20.7 | 28,398 | 18.8 |
Male | 16,501 | 80.7 | 19,531 | 82.5 | 25,412 | 82.2 | 30,580 | 81.9 | 30,908 | 79.3 | 122,932 | 81.2 |
Age group (in years) | ||||||||||||
5-9 | 256 | 1.3 | 201 | 0.8 | 219 | 0.7 | 298 | 0.8 | 213 | 0.5 | 1,187 | 0.8 |
10-14 | 3,540 | 17.3 | 3,879 | 16.5 | 4,783 | 15.5 | 5,200 | 13.9 | 5,608 | 14.5 | 23,010 | 15.2 |
15-19 | 16,646 | 81.4 | 19,582 | 82.7 | 25,900 | 83.8 | 31,837 | 85.3 | 33,168 | 85.0 | 127,133 | 84.0 |
Ethnicity/skin color | ||||||||||||
White | 6,835 | 33.4 | 7,105 | 30.0 | 8,083 | 26.2 | 10,434 | 27.9 | 11,584 | 29.7 | 44,041 | 29.1 |
Black | 1,136 | 5.6 | 1,145 | 4.8 | 1,482 | 4.8 | 1,741 | 4.7 | 1,828 | 4.7 | 7,332 | 4.9 |
Brown | 4,245 | 20.8 | 4,353 | 18.4 | 5,373 | 17.4 | 7,381 | 19.8 | 8,268 | 21.2 | 29,620 | 19.6 |
Asian | 274 | 1.3 | 284 | 1.2 | 264 | 0.8 | 261 | 0.7 | 448 | 1.1 | 1,531 | 1.0 |
Indigenous | 9 | 0.0 | 5 | 0.0 | 3 | 0.0 | 22 | 0.1 | 30 | 0.1 | 69 | 0.0 |
No information | 7,943 | 38.9 | 10,770 | 45.6 | 15,697 | 50.8 | 17,496 | 46.8 | 16,831 | 43.2 | 68,737 | 45.4 |
Cause of attendance | ||||||||||||
F10 a (alcohol) | 2,242 | 11.0 | 2,620 | 11.1 | 2,699 | 8.7 | 2,849 | 7.6 | 3,207 | 8.2 | 13,617 | 9.0 |
F11 b (opioid) | 80 | 0.4 | 76 | 0.3 | 86 | 0.3 | 123 | 0.3 | 182 | 0.5 | 547 | 0.4 |
F12 c (cannabinoids) | 2,924 | 14.3 | 3,600 | 15.2 | 4,455 | 14.4 | 5,870 | 15.7 | 6,729 | 17.2 | 23,578 | 15.6 |
F13 d (sedatives) | 62 | 0.3 | 51 | 0.2 | 92 | 0.3 | 120 | 0.3 | 53 | 0.1 | 378 | 0.2 |
F14 e (cocaine) | 2,511 | 12.3 | 3,284 | 13.9 | 5,145 | 16.6 | 6,721 | 18.0 | 6,026 | 15.5 | 23,687 | 15.6 |
F15 f (stimulants) | 150 | 0.7 | 49 | 0.2 | 71 | 0.2 | 151 | 0.4 | 181 | 0.5 | 602 | 0.4 |
F16 g (hallucinogens) | 29 | 0.1 | 50 | 0.2 | 51 | 0.2 | 226 | 0.6 | 70 | 0.2 | 426 | 0.3 |
F17 h (tobacco) | 258 | 1.3 | 186 | 0.8 | 262 | 0.8 | 312 | 0.9 | 321 | 0.9 | 1,339 | 0.9 |
F18 i (solvents) | 470 | 2.3 | 294 | 1.2 | 255 | 0.8 | 197 | 0.6 | 161 | 0.4 | 1,377 | 0.9 |
F19 j (multiples SPAk) | 11,716 | 57.3 | 13,452 | 56.9 | 17,786 | 57.6 | 20,766 | 55.6 | 22,059 | 56.6 | 85,779 | 56.7 |
Total | 20,442 | 13.5 | 23,662 | 15.6 | 30,902 | 20.4 | 37,335 | 24.7 | 39,119 | 25.8 | 151,330 | 100.0 |
a) F10: Mental and behavioral disorders due to use of alcohol.
b) F11: Mental and behavioural disorders due to use of opioids.
c) F12: Mental and behavioral disorders due to use of cannabinoids.
d) F13: Mental and behavioral disorders due to the use of sedatives and hypnotics.
e) F14: Mental and behavioral disorders due to use of cocaine.
f) F15: Mental and behavioral disorders due to use of other stimulants, including caffeine.
g) F16: Mental and behavioral disorders due to the use of hallucinogens.
h) F17: Mental and behavioral disorders due to use of tobacco.
i) F18: Mental and behavioral disorders due to use of volatile solvents.
j) F19: Mental and behavioral disorders due to use of multiple drugs and the use of other psychoactive substances.
k) SPA: Psychoactive Substances.
Sources: Authorization for outpatient procedures (APAC); International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10).
Type of CAPS | Region | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
North | Northeast | Southeast | South | Midwest | ||||||||
n | % | n | % | n (63,165) | % | n | % | n | % | n | % | |
CAPS Ia | 210 | 5.7 | 2,098 | 7.4 | 981 | 1.6 | 2,416 | 5.3 | 307 | 2.8 | 6,012 | 4.0 |
CAPS IIb | 98 | 2.7 | 417 | 1.5 | 4,645 | 7.4 | 215 | 0.5 | 7 | 0.1 | 5,382 | 3.5 |
CAPS IIIc | 6 | 0.2 | 176 | 0.6 | 222 | 0.3 | 17 | 0.0 | 95 | 0.9 | 516 | 0.3 |
CAPSid | 39 | 1.0 | 2,664 | 9.4 | 6,380 | 10.1 | 6,482 | 14.3 | 129 | 1.2 | 15,694 | 10.4 |
CAPS ADe / CAPS AD IIIf | 3,322 | 90.4 | 22,973 | 81.1 | 50,937 | 80.6 | 36,245 | 79.9 | 10,249 | 95.0 | 123,726 | 81.8 |
Total | 3,675 | 100.0 | 28,328 | 100.0 | 63,165 | 100.0 | 45,375 | 100.0 | 10,787 | 100.0 | 151,330 | 100.0 |
a) CAPS I: Psychosocial Care Center type I.
b) CAPS II: Psychosocial Care Center type II.
c) CAPS III: Psychosocial Care Center type III.
d) CAPSi: Psychosocial Care Center for Childhood and Youth.
e) CAPS AD: Psychosocial Care Center for Alcohol and other Drugs.
f) CAPS AD III: Psychosocial Care Center for Alcohol and other Drugs 24 Hours.
Sources: Authorization for outpatient procedures (APAC); National Database on Health Units (CNES).
Access the original article at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222018000200300&lng=pt&nrm=iso&tlng=en
In the article “Prevalence of health services utilization in Brazil: a systematic review and meta-analysis”, doi No. http://dx.doi.org/10.5123/s1679-49742017000300016, published on Epidemiology and Health Services, 26(3):
Original text:
Figure 2 presents the prevalences of medical visits found in the 18 studies,17-20,22-25,27,29-34,36,37,44
Corrected text:
Figure 2 presents the prevalences of medical visits found in the 18 studies,17-25, 27, 29-34, 36, 37
Pages 597 to 599:
N.B.: The following references should be taken to have one number less than the number shown, i.e. consult the reference immediately prior to the reference cited.
Original text: | Corrected text: |
---|---|
45 | 44 |
46 | 45 |
47 | 46 |
48 | 47 |
49 | 48 |
50 | 49 |
51 | 50 |
52 | 51 |
53 | 52 |
54 | 53 |
55 | 54 |
56 | 55 |
57 | 56 |
58 | 57 |
59 | 58 |
60 | 59 |
61 | 60 |
62 | 61 |
63 | 62 |
64 | 63 |
65 | 64 |
66 | 65 |
67 | 66 |
68 | 67 |
69 | 68 |
70 | 69 |
71 | 70 |
72 | 71 |
73 | 72 |
74 | 73 |
75 | 74 |
Access the original article at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222017000300589&lng=pt&nrm=iso&tlng=pt
In the article “Congenital syndrome associated with Zika virus infection among live births in Brazil: a description of the distribution of reported and confirmed cases in 2015-2016”, DOI: 10.5123/S1679-49742018000200014, published on Epidemiology and Health Services, 27(2):1-12, page 10:
Original text:
França GVA and Garcia LP participated in the conception and design of the study. França GVA, Garcia LP, I RV, Carmo GMI, loyal MB and Garcia MHO performed the analysis and interpretation of the results, writing and critical review of the manuscript.
Corrected text:
França GVA and Garcia LP participated in the conception and design of the study. França GVA, Garcia LP, Pedi VD, Carmo GMI, Leal MB and Garcia MHO performed the analysis and interpretation of the results, writing and critical review of the manuscript.